Skip to main content

Month: September 2021

Selecta Biosciences to Participate in Cantor Virtual Global Healthcare Conference

WATERTOWN, Mass., Sept. 21, 2021 (GLOBE NEWSWIRE) — Selecta Biosciences, Inc. (NASDAQ: SELB), a biotechnology company leveraging its clinically validated ImmTOR™ platform to develop tolerogenic therapies that selectively mitigate unwanted immune responses, today announced that Company’s Management will participate in a fireside chat and one-on-one investor meetings at the Cantor Virtual Global Healthcare Conference to be held September 27-30, 2021. Details on the conference be found below. Cantor Virtual Global Healthcare ConferenceFormat: Fireside chat and one-on-one investor meetingsDate: Monday September 27, 2021Presentation Time: 3:20 p.m. ESTWebcast: Click Here An archived webcast will also be accessible in the Investors & Media section of the company’s website at www.selectabio.com. About Selecta Biosciences, Inc.Selecta...

Continue reading

Longeveron Announces Dr. Jorge Ruiz as Speaker for Roundtable Discussion & Presentation at 2021 International Conference for Frailty & Sarcopenia Research

— Jorge Ruiz, M.D., Associate Director for Clinical Affairs, Geriatric Research at the Miami VA Healthcare System, will present Longeveron’s Aging Frailty Phase 2b Trial Data — National Institute on Aging-funded study showed significant, dose-dependent improvement in walking distance after infusion with Lomecel-B in subjects with mild-to-moderate Aging Frailty MIAMI, Sept. 21, 2021 (GLOBE NEWSWIRE) — Longeveron Inc. (NASDAQ: LGVN) (“Longeveron” or “Company”), a clinical stage biotechnology company developing cellular therapies for chronic aging-related and life-threatening conditions, today announced that Jorge Ruiz, M.D., Associate Director for Clinical Affairs at the Geriatric Research, Education and Clinical Center (GRECC), Miami Veterans Affairs Healthcare System, and lead investigator in...

Continue reading

Aspira Women’s Health Inc. to Present at the Cantor Fitzgerald Virtual Global Healthcare Conference

AUSTIN, Texas, Sept. 21, 2021 (GLOBE NEWSWIRE) — Aspira Women’s Health, Inc. (Nasdaq: AWH), a bioanalytical-based women’s health company, today announced that it will present at the Cantor Fitzgerald Virtual Global Healthcare Conference on Wednesday, September 29th, 2021. Details for the presentation are below:Date: September 29th, 2021Time: 4:40pm ETWebcast https://wsw.com/webcast/cantor12/awh/1906240Management will also be available for virtual 1×1 meetings. To request a meeting, please contact corporateaccess@cantor.com. About ASPIRA Women’s Health Inc.Aspira Women’s Health Inc. (formerly known as Vermillion, Inc., Nasdaq: VRML) is transforming women’s health with the discovery, development, and commercialization of innovative testing options and bio-analytical solutions that help physicians assess risk, optimize...

Continue reading

Investview (“INVU”) Announces Another Strong Month of Gross Revenue and Net Income Across Business Divisions – with Record Membership Subscription Sales for August 2021

Investview Continues Strong Monthly Results Across Business Divisions: August 2021 Gross Revenue Growth of 223% year-over-year to $9.8 million and Net Income Growth of 823% year-over-year to $3.7 million.Gross Revenue of $9.8 million, up 223% Year-Over-Year August Income from Operations of $3.4 million, up 1,213% Year-Over-Year August Net Revenue of $8.7 million, up 198% Year-Over-Year August Net Income of $3.7 million (includes non-operating income), up $4.3 million or 823% Year-Over-Year August iGenius Subscription and NDAU Gross Revenue of $6.6 million, up 216% Year-Over-Year August iGenius Membership Subscription Record Gross Revenue of $5.4 million, up 155% Year-Over-Year August SAFETek Bitcoin Mining Gross Revenue of $3.1 million, up 238% Year-Over-Year August Bitcoin Mined over 16 months period ending August 2021, 1,072.43 Bitcoin Digital...

Continue reading

CoreCivic Enters Into New Lease Agreement with the State of New Mexico at the Northwest New Mexico Correctional Center

BRENTWOOD, Tenn., Sept. 21, 2021 (GLOBE NEWSWIRE) — CoreCivic, Inc. (NYSE: CXW) (the Company) announced today that it has entered into a new three-year lease agreement with the State of New Mexico at the Company’s 596-bed Northwest New Mexico Correctional Center. CoreCivic currently operates the Northwest New Mexico Correctional Center under a contract with New Mexico and will transition facility operations to the New Mexico Corrections Department when the new lease agreement commences on November 1, 2021. CoreCivic will retain responsibility for facility maintenance throughout the term of the lease. The new lease agreement includes automatic extension options that could extend the term of the lease through October 31, 2041. Damon T. Hininger, CoreCivic’s President and Chief Executive Officer, said, “We are pleased...

Continue reading

Provectus Biopharmaceuticals Announces Presentation of Full Study Data from Metastatic Neuroendocrine Cancer Phase 1 Trial of PV-10® at European Society for Medical Oncology (ESMO) Congress 2021

KNOXVILLE, TN, Sept. 21, 2021 (GLOBE NEWSWIRE) — Provectus (OTCQB: PVCT) today announced that data from an ongoing clinical trial of investigational cancer immunotherapy PV-10 (rose bengal disodium) for the treatment of neuroendocrine tumors (NET) metastatic to the liver (mNET) refractory to somatostatin analogs (SSAs) and peptide receptor radionuclide therapy (PRRT) (NCT02693067) was presented at the European Society for Medical Oncology (ESMO) Congress, held online from September 16-21, 2021. Highlights from the ESMO 2021mNET Presentation:Baseline disease characteristicsN = 12 patients: 50% male; median age of 66 years (range 47-79) Primary tumor sites: 7 small bowel (58%), 2 pancreas (17%), 1 caecal (8%), and 2 unknown (17%) NET grades: 5 Grade 1 (42%) and 7 Grade 2 (58%) Refractory to SSA and PRRT; all symptomatic progressive...

Continue reading

Almost Half of Women Are Considering a Career Change to Pursue More Money and Flexibility, According to a New Survey from LinkedIn and Marie Claire

Data Suggests Work-From-Home Options Will be Essential to Workforce Recovery in the Coming Year NEW YORK, Sept. 21, 2021 (GLOBE NEWSWIRE) — Almost half of women (48%) are considering a career change in the next year to pursue work-from-home flexibility and more money, according to a new survey from LinkedIn, Marie Claire and Future plc. Among the findings, 40% of respondents are currently working full-time from home, 49% are working full-time from a workplace, and 11% are splitting time between the two. The survey asked 1,132 women and non-binary full-time U.S. workers about their experiences and challenges during the course of the pandemic, as well their hopes and expectations for the future of work. For those who worked from home during the pandemic, 41% want to remain working from home full-time, 33% want to return to their...

Continue reading

Nuwellis Receives CE Mark for 24-Hour Blood Circuit Set

Certification will help Nuwellis meet clinical and healthcare economic needs in Europe and make outpatient ultrafiltration treatment more accessible EDEN PRAIRIE, Minn., Sept. 21, 2021 (GLOBE NEWSWIRE) — Nuwellis, Inc. (NASDAQ: NUWE), a company focused on providing solutions for patients suffering from fluid overload, today announced that it has received CE Mark Certification for its 24-Hour Blood Circuit Set (UF 500-24 Hour). The UF 500-24 Hour blood circuit set is only to be used with the company’s Aquadex SmartFlow® system. The CE marking allows Nuwellis to market the 24-hour Blood Circuit in the European Union (EU) and all other countries that recognize this certification. The new device will help Nuwellis expand access to ultrafiltration among patients who need no more than 24 hours of Aquadex therapy in the inpatient...

Continue reading

Enigmai, a Wholly-Owned Subsidiary of Golden Star Enterprises Ltd., Investigating the Growing Need for Workforce Management in Hospitals

Claymont, DE, Sept. 21, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — Golden Star Enterprises Ltd., (OTCPink: GSPT) today announced that its wholly-owned subsidiary, Enigmai, has determined to assign a team to investigate the benefits of implementing its Enigmai Business Suite (EBS) workforce management system (WFM) in hospitals. Golden Star Enterprises CEO, Eliav Kling, commented, “Hospital schedules are complex. You must have the right staff in every shift in order to operate the hospital in an efficient manner and also provide and maintain a high level of service. Mr. Tim Cadeau, one of our new additions to our recently formed Advisory Board, has been managing some of Canada’s largest hospital unions for the last 10 years. Mr. Cadeau’s experience in this sector suggests that approximately 90% of the conflicts between hospitals...

Continue reading

Highly Anticipated Global Pre-Order Portal Now Open for Terravis Solar & COR Battery System Products

Worksport LtdTerravis Solar & COR Battery System ProductsMississauga, Sept. 21, 2021 (GLOBE NEWSWIRE) — Worksport Ltd (Nasdaq-CM: WKSP; WKSPW) (“Worksport” or the “Company”) is excited to present the market with a pre-order portal (www.goterravis.com) for its flagship solar-integrated tonneau cover and COR mobile energy storage system (ESS). The website will allow customers from around the world to be first in line to receive the highly anticipated Terravis mobile solar generator and COR energy storage system. This culminates years of effort in providing the market with a simple way of getting the first-of-its-kind, solar-integrated tonneau cover and COR mobile energy storage systems. Management believes this is a once-in-a-generation opportunity for EV startup manufacturers, well-established automotive manufacturers,...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.